The lack of Tr1 differentiation in MS was recently confirmed by another study [20] and in a primate model of MS [21], and the dysregulation of CD46 pathways in T cells was recently described in patients with asthma [22] and with rheumatoid arthritis [17]. This evidence concerns the gene CD46 and myeloid sarcoma.